Novartis's new chief sets sights on 'productivity revolution' | Financial Times
Novartis to acquire US-based cancer drugmaker Endocyte for $2.1 billion | Business Standard News
Vas Narasimhan, CEO Of Novartis: Transforming Standards Of Patient Care - Outside Lens
Amazon could partner with a PBM to blaze its trail into pharma: analysts | Fierce Pharma
Leaders with Lacqua: Vasant Narasimhan, Novartis CEO - YouTube
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Vas Narasimhan at the 2019 One Young World Summit - Human Engineers
News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis — People Matters
Novartis CEO says U.S. rebate plan will return cash to patients | Reuters
Novartis CEO Cautions on Efficacy of Trump-Touted Covid-19 Treatment - TheStreet
The 'student' of leadership who seeks to inspire his employees | Financial Times
Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager magazin
Speakers · Total Health · Chicago, October 19-20, 2022
Amazon.com: Vasant Narasimhan: Books
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more | Fierce Pharma
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Speakers · Total Health · Chicago, October 19-20, 2022
The CEO of Swiss pharma giant Novartis voluntarily gave up $400,000 of his bonus, thanks to a controversy swirling around the world's most expensive drug | Business Insider India
Digital transformation in the life sciences supply chain – show me the data | Kinaxis
Agenda · Total Health · Chicago, October 19-20, 2022
Novartis says all options open on Sandoz after private equity interest emerges - Jnews
A Year In, Novartis' Boss Faces The World
Ousted Novartis scientist denies wrongdoing in data manipulation scandal - Super News
Committed to growing over 4% through 2026, says Novartis CEO
Novartis CEO Narasimhan says he was 'completely blindsided' by Cohen deal revelation | Fierce Pharma
